文献速递细胞病理与分子病理

核评分联合cyclin D1免疫细胞化学在甲状腺不确定滤泡结节穿刺中的诊断价值

[Diagnostic values of nuclear score combined with cyclin D1 immunocytochemistry in indeterminate thyroid follicular nodules in preoperative fine needle aspiration].
PubMed 文献 · Zhonghua Bing Li Xue Za Zhi · 2023-01-01

该研究纳入118例术前细针穿刺细胞学诊断为TBSRTC Ⅲ~Ⅴ级且有组织病理学随访的甲状腺病变,评估简化核形态评分联合cyclin D1免疫细胞化学的诊断效能。结果显示联合检测诊断恶性/低危肿瘤的准确性提高至94.1%,为细胞病理医师提供了简单准确的辅助诊断方法,可能减少不必要的甲状腺切除术。

要点

  • 简化核评分≥2分诊断恶性/低危肿瘤灵敏度99.0%、特异度50.0%。
  • cyclin D1阳性阈值10%时特异度100%、灵敏度88.5%。
  • 联合检测准确性94.1%,灵敏度93.3%,PPV 100%。

核心结论

  • 对FNA细胞学不确定的甲状腺结节,简化核评分联合cyclin D1免疫细胞化学可提高诊断准确性。
  • 该辅助方法简单、准确、方便,可能减少不必要的甲状腺切除术。

研究设计与样本

  • 回顾性收集2018年12月至2022年4月北京医院病理科118例有组织病理学随访的甲状腺FNA标本,细胞学诊断为TBSRTC Ⅲ~Ⅴ级。
  • 行细胞形态学评估及涂片退染cyclin D1免疫细胞化学染色,用ROC曲线和AUC确定最佳临界值。
  • 通过交叉列联表评价各指标效能,ROC曲线分析评价联合诊断准确性。

主要发现

  • 核沟、核内包涵体及核淡染更常见于恶性/低危甲状腺结节(P=0.001、0.012、0.001)。
  • 简化核评分≥2分诊断恶性/低危肿瘤的PPV 93.6%、NPV 87.5%、灵敏度99.0%、特异度50.0%。
  • cyclin D1阳性阈值10%时诊断恶性/低危肿瘤的PPV 100%、NPV 53.8%、灵敏度88.5%、特异度100%。
  • 联合检测诊断恶性/低危肿瘤的灵敏度93.3%、PPV 100%、特异度100%、NPV 66.7%。
  • 联合检测诊断准确性提高至94.1%,高于单独使用任一方法。

关键数值与推荐

  • 简化核形态评分阳性阈值:≥2分。
  • cyclin D1免疫细胞化学阳性阈值:阳性甲状腺细胞占10%。
  • 联合检测诊断恶性/低危肿瘤的准确性94.1%。

临床怎么用

  • 对TBSRTC Ⅲ~Ⅴ级不确定甲状腺FNA病例,可加做简化核评分和cyclin D1免疫细胞化学辅助分类。
  • 联合检测高PPV和特异度有助于确认恶性/低危肿瘤,可能减少不必要的甲状腺切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To assess the feasibility of nuclear score combined with cyclin D1 immunocytochemistry in classifying indeterminate thyroid nodules with fine-needle aspiration (FNA) cytological diagnosis of Bethesda category Ⅲ-Ⅴ. Methods: A consecutive cohort of 118 thyroid FNA specimens with indeterminate diagnosis (TBSRTC category Ⅲ-Ⅴ) and available histopathologic follow-up data were collected between December 2018 and April 2022 at the Department of Pathology, Beijing Hospital, China. These cases were subjected to cytological evaluation and cyclin D1 immunocytochemistry. The optimal cut-off points of a simplified nuclear score and the percentage of cyclin D1-positive cells for the diagnosis of malignancy or low-risk neoplasm were determined using the receiver operating characteristic (ROC) curves and area under the ROC curve (AUC). The specificity, sensitivity, positive predictive value (PPV) and negative predictive value (NPV) of nuclear score and cyclin D1 immunostaining were evaluated from the crosstabs based on cut-off points. The diagnostic accuracy of simplified nuclear score combined with cyclin D1 immunostaining was estimated using ROC curve analysis. Results: Nuclear grooves, intra-nuclear inclusions and chromatin clearing were more commonly found in malignancy/low-risk neoplasms than benign lesions (P=0.001, P=0.012 and P=0.001 respectively). A cut-off point of≥2 for the simplified nuclear score was sensitive for defining malignancy/low-risk neoplasm, and its PPV, NPV, sensitivity and specificity were 93.6%, 87.5%, 99.0% and 50.0% respectively. A positive cut-off point of 10% positive thyroid cells in cyclin D1 immunostaining demonstrated sensitivity of 88.5%, specificity of 100%, PPV of 100% and NPV of 53.8% for correctly detecting thyroid malignancy or low-risk neoplasm. The sensitivity and PPV of simplified nuclear score combined with cyclin D1 immunostaining were 93.3% and 100%, respectively. Both specificity and NPV were maintained at high levels (100% and 66.7%, respectively). The diagnostic accuracy of simplified nuclear score combined with cyclin D1 immunostaining in detecting thyroid malignancy/low-risk neoplasm was increased to 94.1% compared to using either of them alone. Conclusions: Combing simplified nuclear score and cyclin D1 immunostaining on FNA cytology specimens can increase the diagnostic accuracy in classifying thyroid nodules of indeterminate cytological categories. Thus, this supplementary approach provides a simple, accurate, and convenient diagnostic method for cytopathologists so that may reduce unnecessary thyroidectomies. 目的: 探讨细胞核形态评分联合细胞周期蛋白D1(cyclin D1)免疫细胞化学染色,用于甲状腺细胞病理学Bethesda报告系统(TBSRTC)分类中不确定类别(Ⅲ~Ⅴ级)病变诊断的可行性。 方法: 收集2018年12月至2022年4月北京医院病理科共118例有组织病理学随访结果,术前穿刺细胞学诊断为TBSRTC Ⅲ、Ⅳ及Ⅴ级的甲状腺滤泡上皮病变。行细胞形态学观察及涂片退染cyclin D1 免疫细胞化学染色。利用受试者工作特征曲线(ROC)和ROC曲线下面积(AUC)评估简化的细胞核形态评分及cyclin D1诊断甲状腺恶性肿瘤的最佳临界值。通过交叉列联表评价各指标的特异度、灵敏度、阳性预测值(PPV)和阴性预测值(NPV),ROC曲线分析评价简化核形态评分联合cyclin D1的诊断准确性。 结果: 核沟、核内包涵体及核淡染更易出现于恶性/低危甲状腺结节(P=0.001,0.012,0.001)。简化的核形态评分的阳性阈值设定为2分,诊断甲状腺恶性/低危肿瘤的灵敏度高,其PPV为93.6%,NPV为87.5%,灵敏度为99.0%,特异度为50.0%。cyclin D1核染色阳性阈值设定为10%,诊断甲状腺恶性/低危肿瘤的PPV为100%,NPV为53.8%,灵敏度为88.5%,特异度为100%。联合核形态评分与cyclin D1免疫细胞化学,诊断甲状腺恶性/低危肿瘤的灵敏度为93.3%,PPV为100%,而特异度和NPV都保持在高水平(100%和66.7%)。与单独使用上述检测方法相比,核形态评分联合cyclin D1 免疫细胞化学,辅助细针穿刺细胞学诊断甲状腺恶性/低危肿瘤的准确性提高至94.1%。 结论: 对细针穿刺细胞学诊断不确定的病例,结合简化核形态评分及cyclin D1免疫细胞化学染色,可以提高细胞学在诊断甲状腺恶性/低危肿瘤中的准确性。这一辅助手段为细胞病理学医师提供了一个简单、准确和方便的诊断方法,同时减少了外科不必要的甲状腺切除手术。.

来源:Zhonghua Bing Li Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. He SR, Liu LT, Chen RM, et al. [Diagnostic values of nuclear score combined with cyclin D1 immunocytochemistry in indeterminate thyroid follicular nodules in preoperative fine needle aspiration]. Zhonghua Bing Li Xue Za Zhi. 2023. PMID: 37408400. doi:10.3760/cma.j.cn112151-20230116-00046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。